Javier L Deira Lorenzo1, Silvia González Sanchidrián2, André Rocha Rodrigues2, Rosa M Ruiz-Calero Cendrero3, Miguel A Suarez Santisteban4, José M Sánchez Montalbán2, Josefa Galán González5, Olga Sánchez García6, María T Hernández Moreno7, Juan Villa Rincón8, María A Fernández Solís9, Clarencio Cebrián Andrada10, Gaspar Tovar Manzano11, Vanesa García-Bernalt Funes4, Alejandro Cives Muiño12, Pedro Dorado Hernández13. 1. Hospital San Pedro de Alcántara, Avda Pablo Naranjo S/N, 10.003, Cáceres, Spain. javierlorenzo.deira@salud-juntaex.es. 2. Hospital San Pedro de Alcántara, Avda Pablo Naranjo S/N, 10.003, Cáceres, Spain. 3. Hospital Universitario de Badajoz, Av. de Elvas, s/n, 06080, Badajoz, Spain. 4. Hospital Virgen del Puerto, Paraje Valcorchero, S/N, 10600, Plasencia, Cáceres, Spain. 5. FMC Badajoz, Av. Manuel Saavedra Martínez, 1A, 06006, Badajoz, Spain. 6. FMC Mérida, Complejo Empresarial Carrión. Avda. Portugal s/n, 06800, Mérida, Badajoz, Spain. 7. FMC Cáceres, Ronda de San Francisco, 10002, Cáceres, Spain. 8. Hospital de Zafra Ctra, Badajoz-Granada, s/n, 06300, Zafra, Badajoz, Spain. 9. FMC Villanueva, C/Doñana, s/n, Urbanización Los Pinos, 06700, Villanueva de la Serena, Badajoz, Spain. 10. FMC Navalmoral, Ctra. Madrid-Lisboa, 29, 10300, Nalvalmoral de la Mata, Cáceres, Spain. 11. FMC Coria, Polígono Ind. Los Rosales-Naves A-B. Planta 1ª, 10800, Coria, Cáceres, Spain. 12. FMC Plasencia, Plaza del Olivar, 10600, Plasencia, Cáceres, Spain. 13. Departamento de Terapéuticas Médicas Quirúrgicas, Universidad de Extremadura, Avda. Virgen del Puerto, 10600, Plasencia, Cáceres, Spain.
Editor,We have read with great interest the most important manuscripts published in Int Urol Nephrol on COVID-19 in hemodialysis (HD) patients [1-5]. As so, we can provide our experience presenting an observational, prospective, multicenter study in a cohort of 668 HD patients from 6 hospital units and 7 peripheral HD centers, obtained between March 11th and April 17th of 2020. In this study, we analyzed the data from all the Rt-PCR collected in all HD units in Extremadura (Spain). The territorial scope exceeds one million people, and the data cover both healthcare settings: hospital and peripheral HD clinics (out-of-hospital).We studied the incidence of COVID-19 in HD patients, the clinical characteristics, the factors related to the infection and the profitability of the diagnosis by Rt-PCR in this population. The number of tests done has to be considered in the context of the first wave of the pandemic in which the magnitude of the health crisis in general population limited the availability of the tests, making its optimization essential. The average number of extractions was 2.6 a day, with a maximum peak of 8 extractions on March 24th. A total of 99 Rt-PCRs were performed in the study period; 14.8% (99/668) of the prevalent HD patients were analyzed using this test. This percentage was higher in hospitals compared to peripheral centers (24.4% vs. 10.8%). 58.6% (58/99) of the samples were obtained in patients with suspected COVID-19 symptoms, the rest were taken from asymptomatic patients. 18.2% of the samples were positive (18/99), a percentage that rises to 25.9% (15/58) in symptomatic patients and falls to 7.3% (3/41) in asymptomatic patients. 72.2% (13/18) of positive samples were from the province of Cáceres (which includes 2 hospital units and 4 peripheral HD centers), where the infection rate among the general population was higher. Cough was the main predictive symptom (p = 0.013), however, including all the parameters in a multivariate analysis, we did not find any variable that reached statistical significance. The incidence of confirmed cases showed an increasing trend between March 13th and April 11th, slowing down in the ultimate week, possibly due to the very restrictive measures adopted by the Spanish government. The prevalence was 2.7% (18/668), with marked variability between hospital and peripheral units and between different health areas. Due to the high percentage of positive patients who were asymptomatic, 7% in our study and up to 40% in others [6], probably both the incidence of confirmed cases and prevalence of COVID-19 in our units are likely to be higher than the rates detected, given the fact that Rt-CRP was not determined in all of patients for the above-mentioned reasons. Nevertheless, the data from our study confirm the tendency known from other studies in our setting [6-10]. This study reflects the exposure and initial management of the pandemic in a region of Spain, which was one of the most severely affected European countries, together with Italy, at the beginning of the pandemic.
Authors: Hernando Trujillo; Fernando Caravaca-Fontán; Ángel Sevillano; Eduardo Gutiérrez; Jara Caro; Elena Gutiérrez; Claudia Yuste; Amado Andrés; Manuel Praga Journal: Kidney Int Rep Date: 2020-05-01
Authors: Marian Goicoechea; Luis Alberto Sánchez Cámara; Nicolás Macías; Alejandra Muñoz de Morales; Ángela González Rojas; Arturo Bascuñana; David Arroyo; Almudena Vega; Soraya Abad; Eduardo Verde; Ana María García Prieto; Úrsula Verdalles; Diego Barbieri; Andrés Felipe Delgado; Javier Carbayo; Antonia Mijaylova; Adriana Acosta; Rosa Melero; Alberto Tejedor; Patrocinio Rodriguez Benitez; Ana Pérez de José; María Luisa Rodriguez Ferrero; Fernando Anaya; Manuel Rengel; Daniel Barraca; José Luño; Inés Aragoncillo Journal: Kidney Int Date: 2020-05-11 Impact factor: 10.612